EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Molecular crosstalk in SP7-mediated osteogenesis: Regulatory mechanisms and therapeutic potential

Jun Lang, Vivek Kumar Morya, Mi-Kyung Kwak, Sin-Hye Park, Kyu-Cheol Noh

Osteoporosis and Sarcopenia · 2025-06 · 11 (2) · 31-37

DOI: 10.1016/j.afos.2025.04.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Osteoporosis and Sarcopenia, 2025-06. Verfasst von Jun Lang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, South Korea. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hallym University, Hallym University Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SP7, also known as Osterix, is a zinc finger-containing transcription factor, plays a crucial role in osteoblast differentiation and bone formation. This review examines the molecular mechanisms underlying SP7's regulatory functions, highlighting its interactions with key signaling pathways such as BMP-SMAD, Wnt/β-catenin, and HIF-1α. SP7 acts downstream of RUNX2 to regulate osteogenic gene expression, including collagen Type I Alpha 1 (COL1A1), alkaline phosphatase (ALP) and osteocalcin (OCN). The review also explores the role of post-translational modifications, such as phosphorylation and ubiquitination, in modulating SP7's stability and activity. Emerging therapeutic strategies targeting SP7, including gene editing, RNA-based approaches, and small-molecule modulators, are discussed as innovative solutions for treating osteoporosis and other skeletal disorders. The potential for future research into SP7's interactions with non-coding RNAs and angiogenesis pathways is emphasized, underscoring its significance in skeletal health and regenerative medicine. This comprehensive overview consolidates current knowledge of SP7's molecular functions, therapeutic potential, and its pivotal role in bone biology.

Schlagwörter

Stichwörter der Autor:innen

BMPHIF-1αOsteogenesisOsteoporosisSOSTSP7

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, South Korea.
  • School of Medicine, Hallym University, Chuncheon, South Korea.
  • Department of Endocrinology and Metabolism, Hallym University Dongtan Sacred Heart Hospital, Dongtan, Hwaseong, South Korea.
  • Department of Food Science & Nutrition, Hallym University, Chuncheon, South Korea.
  • Department of Orthopedic Surgery, Hallym University Sacred Heart Hospital, Anyang, South Korea.

Förderung

  • Hallym University
  • Hallym University Medical Center

Zitieren

APA

Lang, J., Morya, V. K., Kwak, M. K., Park, S. H., & Noh, K. C. (2025). Molecular crosstalk in SP7-mediated osteogenesis: Regulatory mechanisms and therapeutic potential. Osteoporosis and Sarcopenia, 11(2), 31-37. https://doi.org/10.1016/j.afos.2025.04.003

Vancouver

Lang J, Morya VK, Kwak MK, Park SH, Noh KC. Molecular crosstalk in SP7-mediated osteogenesis: Regulatory mechanisms and therapeutic potential. Osteoporosis and Sarcopenia. 2025;11(2):31-37. doi:10.1016/j.afos.2025.04.003

BibTeX
@article{Lang2025,
  author = {Lang, Jun and Morya, Vivek Kumar and Kwak, Mi-Kyung and Park, Sin-Hye and Noh, Kyu-Cheol},
  title = {Molecular crosstalk in SP7-mediated osteogenesis: Regulatory mechanisms and therapeutic potential},
  journal = {Osteoporosis and Sarcopenia},
  year = {2025},
  volume = {11},
  number = {2},
  pages = {31--37},
  doi = {10.1016/j.afos.2025.04.003}
}
Kostenlos starten →